Cerebral Cavernous Malformation

topic on 1 show · 1 statements across 1 episodes

Top Founders

1 statements about Cerebral Cavernous Malformation, every show

TOP FOUNDERS Disclosure
Gibson: Recursion is eight months from clinical trials for CCM
“We also have an internal pipeline of drugs that we're developing ourselves one of those is just about eight months away from clinical trials now for a disease called cerebral cavernous malformation.”
Chris Gibson Apr 17, 2017 ▶ 4:20 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.